Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Finasteride was successfully synthesized from Pregnadienolone acetate.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Piperonylic acid may help hair growth and treat hair loss.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Ethanol changes GABAA receptor α4 subunit levels through phosphorylation and neuroactive steroids.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.